| | | Seattle Genetics enters antibody-drug conjugate technology pact with GSK |  | Advertisements: |
|  12/23/09 Seattle Genetics, Inc, has entered into a collaboration agreement with GlaxoSmithKline (GSK) under which GSK will pay an upfront fee of US$ 12 million for rights to utilize Seattle Genetics' antibody-drug conjugate (ADC) technology with multiple antigens to be named by GSK. READ FULL SOURCE |
Back to: Bothell WA news
Other news05/19/11 Seattle Genetics, Inc. today announced that data from its brentuximab vedotin and SGN-75 programs will be reported at the upcoming American Society of Clinical Oncology 2011 Annual Meeting being held June 3-7, 2011 in Chicago, IL.
06/15/11 Seattle Genetics, Inc. today announced that data from its brentuximab vedotin and dacetuzumab programs will be presented at the 11th International Conference on Malignant Lymphoma being held June 15-18, 2011 in Lugano, Switzerland.
07/14/11 SILVER SPRING, Maryland (Reuters) - A U.S. advisory panel backed an experimental drug from Seattle Genetics Inc for treating two rare types of blood cancer, but recommended stricter labeling than the company sought. Hot themes this week:
|
| |
| | HOT towns and cities: Northport, WA news • Mead, WA news • Newman Lake, WA news • Oak Harbor, WA news • South Hill, WA news • Dayton, WA news • Roy, WA news • East Side, WA news • Nine Mile Falls, WA news • Maple Valley, WA news • Bryant, WA news • North Seattle, WA news • Green Lake, WA news | |
|
(c) ProvinceCity.com - news and events from small towns, cities and megapolises.
All rights reserved. |
| |
Home Sitemap 0 news added |
|
|
